Technological innovation in dementia care:
- diagnosis, assessment and monitoring using innovative technologies;
- wearables, smart home systems, robots, virtual reality (VR), augmented reality (AR), artificial intelligence (AI);
- prevention and technologies to monitor dementia risk factors;
- assistive technologies in dementia care;
- computerised cognitive and physical training;
- Cognitive Assistive Technologies;
- remote monitoring using sensors and analytics;
- warm technology.
- Cognitive Assistive Technology;
- virtual reality;
- augmented reality;
- artificial intelligence;
- remote monitoring;
- warm technology.
Medication and polypharmacy in dementia, incl. pharmacological and non-pharmacological treatments:
- evidence-based pharmacological treatments for dementia (efficacy and acceptability);
- irrational and rational polypharmacy in patients with dementia;
- strategies for rational prescribing in patients with dementia;
- management of behavioural and psychological symptoms in dementia (BPSD) and mental disorders in demented patients;
- medication problems at the different care levels (e.g. from primary care to nursing homes and hospitals);
- non-pharmacological treatments in dementia instead of medications (why and when?);
- collaborative care in pharmacotherapy of demented patients.
- dementia pharmacotherapy;
- evidence-based pharmacotherapy;
- prescribing strategies;
- prescribing and deprescribing;
- medication problems;
- care levels;
- non-pharmacological treatments;
- collaborative care.
Research in dementia including the “nine potentially modifiable risk factors… : low educational level in childhood, hearing loss, hypertension, obesity, smoking, depression, physical inactivity, social isolation, and diabetes.”*
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S.G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J. and Cooper, C., 2017. Dementia prevention, intervention, and care. The Lancet, 390(10113), p.2615.